89Bio Inc (ETNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 93,360 | 11,257 | N/A | N/A | N/A |
| TOTAL | $95,326 | $11,316 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 155 | 33 | N/A | N/A | N/A |
| Other Non-Current Assets | 72 | 20 | 0 | 0 | 0 |
| TOTAL | $227 | $53 | $N/A | $N/A | $N/A |
| Total Assets | $95,553 | $11,369 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 989 | 1,509 | 0 | 0 | 0 |
| Accrued Expenses | 4,620 | 1,173 | N/A | N/A | N/A |
| Other current liabilities | N/A | 1,671 | N/A | N/A | N/A |
| TOTAL | $5,609 | $4,353 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 23,073 | 0 | 0 | 0 |
| TOTAL | $N/A | $23,073 | $N/A | $N/A | $N/A |
| Total Liabilities | $5,609 | $27,426 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,789 | N/A | N/A | N/A | N/A |
| Common Shares | 14 | 1 | N/A | N/A | N/A |
| Retained earnings | -73,596 | -16,176 | N/A | N/A | N/A |
| TOTAL | $89,944 | $-16,057 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $95,553 | $11,369 | $0 | $0 | $0 |